BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23512344)

  • 1. C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.
    Kawamata F; Homma S; Kamachi H; Einama T; Kato Y; Tsuda M; Tanaka S; Maeda M; Kajino K; Hino O; Takahashi N; Kamiyama T; Nishihara H; Taketomi A; Todo S
    J Gastroenterol; 2014 Jan; 49(1):81-92. PubMed ID: 23512344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma.
    Kim H; Chung Y; Paik SS; Jang K; Shin SJ
    Medicine (Baltimore); 2019 Jun; 98(26):e16207. PubMed ID: 31261569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.
    Einama T; Homma S; Kamachi H; Kawamata F; Takahashi K; Takahashi N; Taniguchi M; Kamiyama T; Furukawa H; Matsuno Y; Tanaka S; Nishihara H; Taketomi A; Todo S
    Br J Cancer; 2012 Jun; 107(1):137-42. PubMed ID: 22644300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
    Ito T; Kajino K; Abe M; Sato K; Maekawa H; Sakurada M; Orita H; Wada R; Kajiyama Y; Hino O
    Oncol Rep; 2014 Jan; 31(1):27-33. PubMed ID: 24146039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
    Yoon DH; Ibrahim A; Tatishchev S; Duldulao MPN; Lee SW; Shin J
    J Surg Oncol; 2021 Dec; 124(7):1091-1097. PubMed ID: 34310720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.
    Foda AA; El-Hawary AK; Hamed H
    Pathol Oncol Res; 2016 Oct; 22(4):725-32. PubMed ID: 27062033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer.
    Kawamata F; Kamachi H; Einama T; Homma S; Tahara M; Miyazaki M; Tanaka S; Kamiyama T; Nishihara H; Taketomi A; Todo S
    Int J Oncol; 2012 Dec; 41(6):2109-18. PubMed ID: 23064529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Nomoto K; Murai Y; Takano Y
    J Clin Pathol; 2007 Jan; 60(1):50-6. PubMed ID: 16698949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.
    Li ZJ; Ying XJ; Chen HL; Ye PJ; Chen ZL; Li G; Jiang HF; Liu J; Zhou SZ
    World J Gastroenterol; 2013 Nov; 19(43):7788-94. PubMed ID: 24282367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
    Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
    ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
    Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
    J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
    Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
    Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.